
Sacral neuromodulation and alterations in brain activity — discussing discrepancies
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

Sacral neuromodulation is used to treat refractory overactive bladder (OAB). Recent research has shown that changes in brain activity during sacral neuromodulation relate to its mechanism of
action and that these changes vary with device settings. Much remains to be discovered about how sacral neuromodulation influences brain activity, but studies are now beginning to elucidate
these effects. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access
Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print
issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to
local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES *
Weissbart, S. J. _ et al_. Specific changes in brain activity in women with overactive bladder after successful sacral neuromodulation with InterStim®: an FMRI study [abstract]. _Neurourol.
Urodyn._ 36 (Suppl. 1), S142–S143 (2017). Google Scholar * Gill, B. C. _ et al_. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. _J. Urol._
http://dx.doi.org/10.1016/j.juro.2017.06.074 (2017). * Blok, B. F. M., Groen, J., Bosch, J. L. H. R., Veltman, D. J. & Lammertsma, A. A. Different brain effects during chronic and acute
sacral neuromodulation in urge incontinent patients with implanted neurostimulators. _BJU Int._ 98, 1238–1243 (2006). Article Google Scholar Download references AUTHOR INFORMATION AUTHORS
AND AFFILIATIONS * Department of Urology, Glickman Urological and Kidney Institute, Mail Stop Q10-1, 9500 Euclid Avenue, Cleveland, 44195, Ohio, USA Bradley C. Gill & Howard B. Goldman *
Lerner College of Medicine, Education Institute, Mail Stop Q10-1, 9500 Euclid Avenue, Cleveland, 44195, Ohio, USA Bradley C. Gill & Howard B. Goldman * Department of Biomedical
Engineering, Lerner Research Institute, Cleveland Clinic, Mail Stop Q10-1, 9500 Euclid Avenue, Cleveland, 44195, Ohio, USA Bradley C. Gill Authors * Bradley C. Gill View author publications
You can also search for this author inPubMed Google Scholar * Howard B. Goldman View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR
Correspondence to Howard B. Goldman. ETHICS DECLARATIONS COMPETING INTERESTS B.C.G. declares no competing interests. H.B.G. received research funding from Medtronic for the work described in
this article. Additionally, H.B.G. serves as a consultant for Medtronic, Allergan, Axonics, Nuvectra, NewUro, and Cook. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE
CITE THIS ARTICLE Gill, B., Goldman, H. Sacral neuromodulation and alterations in brain activity — discussing discrepancies. _Nat Rev Urol_ 14, 697–698 (2017).
https://doi.org/10.1038/nrurol.2017.188 Download citation * Published: 14 November 2017 * Issue Date: December 2017 * DOI: https://doi.org/10.1038/nrurol.2017.188 SHARE THIS ARTICLE Anyone
you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the
Springer Nature SharedIt content-sharing initiative